Lyon Joseph Douglas's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Apr 2, 2025
- Accession no.
- 0000950170-25-049813
- Filed
- Apr 2, 2025
- Trade date
- Mar 31-Apr 1, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 5 derivative transactions. Open-market sales total $20.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lyon Joseph DouglasCIK 0001817838 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Common Stock | MOption exerciseAcquired | +35,000 | $13.56 | +$474,600 | 44,009 | Direct | |
| Mar 31, 2025 | Common Stock | MOption exerciseAcquired | +75,000 | $16.52 | +$1,239,000 | 119,009 | Direct | |
| Mar 31, 2025 | Common Stock | MOption exerciseAcquired | +40,000 | $15.82 | +$632,800 | 159,009 | Direct | |
| Mar 31, 2025 | Common Stock | MOption exerciseAcquired | +50,000 | $19.26 | +$963,000 | 209,009 | Direct | |
| Mar 31, 2025 | Common Stock | SSaleDisposed | −162,008 | $100.22F3 | −$16,236,441.76 | 47,001 | Direct | |
| Mar 31, 2025 | Common Stock | SSaleDisposed | −32,942 | $101.37F4 | −$3,339,330.54 | 14,059 | Direct | |
| Mar 31, 2025 | Common Stock | SSaleDisposed | −5,050 | $102.48F5 | −$517,524 | 9,009 | Direct | |
| Apr 1, 2025 | Common Stock | MOption exerciseAcquired | +650 | $13.56 | +$8,814 | 9,659 | Direct | |
| Apr 1, 2025 | Common Stock | SSaleDisposed | −650 | $114.53F6 | −$74,444.5 | 9,009 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Common Stock | MOption exerciseDisposed | −35,000 | $0.00 | $0 | 56,571 | Direct | |
| Mar 31, 2025 | Common Stock | MOption exerciseDisposed | −75,000 | $0.00 | $0 | 0 | Direct | |
| Mar 31, 2025 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 0 | Direct | |
| Mar 31, 2025 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 50,000 | Direct | |
| Apr 1, 2025 | Common Stock | MOption exerciseDisposed | −650 | $0.00 | $0 | 55,921 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $100.00 to $100.98 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $101.00 to $101.90 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $102.00 to $102.705 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.29 to $114.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
Chief Accounting & Technology Officer